ScreenerHero

FLERIE Flerie AB (publ)

STO · SE · Healthcare · Biotechnology · flerie.com
15.40SEK-0.65%Mkt Cap: 127.71M $P/E: —

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap127.71M USD
Enterprise Value104.44M USD
Revenue (TTM)-535.65K USD
Gross Profit-2.46M USD
Net Income (TTM)-72.40M USD
Revenue/Share-0.07 SEK
Last Price15.40 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0022447348
Valuation
P/E (Trailing)—
P/E (Forward)-39.27
PEG—
EV/EBITDA-27.09
EV/Revenue-194.97
P/S-249.26
P/B0.41
EPS (TTM)-9.52
EPS (Forward)-0.41
52W Range
15.101% of range37.41
52W High37.41 SEK
52W Low15.10 SEK
Profitability
Gross Margin0.00%
Oper. Margin-746.15%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-22.41%
ROA-22.28%
Growth
Revenue Growth-85.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.69M USD
CapEx (TTM)—
FCF Margin490.84%
FCF Yield-2.06%
Net Debt-29.08M USD
Net Debt/EBITDA7.54
Balance Sheet
Debt/Equity0.00
Current Ratio66.45
Quick Ratio38.05
Book Value/Sh39.15 SEK
Cash/Share3.53 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split8:7
Split DateMay 15, 2026
Analyst Consensus
Rating—
Target (Mean)26.00 SEK
Upside (mean)+68.8%
Target Range26.00 SEK – 26.00 SEK
# Analysts1
Ownership
Shares Out.86.70M
Float22.43M
Insiders74.93%
Institutions15.35%
Technical
SMA 5018.68 (-17.6%)
SMA 20024.71 (-37.7%)
Beta-0.44
S&P 52W Chg14.58%
Avg Vol (30d)30.80K
Avg Vol (10d)31.75K
Technical Indicators
RSI (14)19.3
MACD-0.7620
MACD Signal-0.6279
MACD Hist.-0.1341
BB Upper18.77 SEK
BB Middle17.14 SEK
BB Lower15.51 SEK
BB Width18.97%
ATR (14)0.6132 SEK
Vol Ratio (20d)0.37x